User login

Australia, Chile Say TPP Biologics Deal Will Not Require Them To Change

October 6, 2015 at 5:16 PM
The top trade officials from Australia and Chile on Monday (Oct. 5) both emphasized that the Trans-Pacific Partnership's (TPP) rules on monopoly periods for biologic drugs will not require any changes to their domestic laws and regulations -- an outcome that has drawn praise from generic pharmaceutical manufacturers but strong criticism from brand-name drug companies. “There should be absolutely no change. What we have succeeded in negotiating is an acceptance that we don't need to move to the American system,...

Not a subscriber? You can request 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Biden era.